Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis SurveyNicola Silvestris, Daniele Santini, Francesco Pantano et al.|PLoS ONE|2013Cited by 67
Somatostatin Analogues according to Ki67 index in neuroendocrine tumours: an observational retrospective-prospective analysis from real lifeAntongiulio Faggiano, Annamaria Colao, Anna Chiara Carratù et al.|Oncotarget|2015Cited by 35
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS groupAnnamaria Colao, Antongiulio Faggiano, Silvana Di Maio et al.|Endocrine|2019Cited by 35
Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer: The IMPROVE TrialAntonio Avallone, Alfredo Budillon, Francesco Giuliani et al.|Journal of Clinical Oncology|2024Cited by 14
Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancerGerardo Rosati, S. Bianco, M. Di Bisceglie et al.|Cancer Chemotherapy and Pharmacology|2019Cited by 4